tiprankstipranks
Trending News
More News >
Thermo Fisher (TMO)
NYSE:TMO
US Market
Advertisement

Thermo Fisher (TMO) Earnings Dates, Call Summary & Reports

Compare
5,001 Followers

Earnings Data

Report Date
Feb 04, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
6.45
Last Year’s EPS
6.1
Same Quarter Last Year
Based on 20 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Oct 22, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance, growth in key segments, and significant strategic initiatives, including collaborations and acquisitions. However, challenges in the diagnostics sector, particularly in China, and pressures in academic and government sectors were noted.
Company Guidance
During Thermo Fisher Scientific's 2025 Third Quarter Conference Call, the company reported a 5% increase in revenue, totaling $11.12 billion, with a 3% organic growth rate and a 1% contribution from acquisitions and foreign exchange. Adjusted operating income rose 9% to $2.59 billion, and adjusted EPS grew 10% to $5.79. The adjusted operating margin expanded by 100 basis points to 23.3%. The company raised its full-year guidance, with revenue now expected to be between $44.1 billion and $44.5 billion and adjusted EPS between $22.60 and $22.86. Strong performance in pharma and biotech sectors was noted, with mid-single-digit growth, while academic and government revenue saw a low single-digit decline. Industrial and Applied revenue grew mid-single digits, and Diagnostics and Healthcare experienced a slight improvement over Q2 but remained down in low single digits. The company also highlighted its strategic collaboration with OpenAI and recent acquisitions, which are expected to enhance its capabilities and support growth.
Strong Financial Performance
Revenue grew 5% to $11.12 billion. Adjusted operating income increased by 9% to $2.59 billion with a 100 basis point expansion in operating margin to 23.3%. Raised full-year guidance for revenue and earnings.
Growth in Pharma and Biotech
Pharma and biotech segments showed mid-single-digit growth, driven by bioproduction and analytical instruments.
Innovation in Clinical Next-Gen Sequencing
FDA approval for OncoMindDx Express test and launch of Oncomine Comprehensive Assay Plus, enhancing genomic profiling and precision medicine.
Significant Collaborations
Strategic collaboration with OpenAI to embed advanced technology into products and operations, enhancing productivity and drug development.
Capital Deployment
Completed acquisition of filtration and separation business, closed acquisition of Ridgefield, NJ sterile finish site, and repurchased $1 billion of shares.
Bioproduction Business Success
Bioproduction business exhibited excellent growth with bookings outpacing revenue growth.

Thermo Fisher (TMO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TMO Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 04, 2026
2025 (Q4)
6.45 / -
6.1
Oct 22, 2025
2025 (Q3)
5.50 / 5.79
5.289.66% (+0.51)
Jul 23, 2025
2025 (Q2)
5.23 / 5.36
5.37-0.19% (>-0.01)
Apr 23, 2025
2025 (Q1)
5.10 / 5.15
5.110.78% (+0.04)
Jan 30, 2025
2024 (Q4)
5.94 / 6.10
5.677.58% (+0.43)
Oct 23, 2024
2024 (Q3)
5.24 / 5.28
5.69-7.21% (-0.41)
Jul 24, 2024
2024 (Q2)
5.12 / 5.37
5.154.27% (+0.22)
Apr 24, 2024
2024 (Q1)
4.71 / 5.11
5.031.59% (+0.08)
Jan 31, 2024
2023 (Q4)
5.64 / 5.67
5.45.00% (+0.27)
Oct 25, 2023
2023 (Q3)
5.61 / 5.69
5.0812.01% (+0.61)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

TMO Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 22, 2025
$557.99$567.20+1.65%
Jul 23, 2025
$427.24$466.29+9.14%
Apr 23, 2025
$433.89$430.81-0.71%
Jan 30, 2025
$566.65$605.06+6.78%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Thermo Fisher (TMO) report earnings?
Thermo Fisher (TMO) is schdueled to report earning on Feb 04, 2026, Before Open (Confirmed).
    What is Thermo Fisher (TMO) earnings time?
    Thermo Fisher (TMO) earnings time is at Feb 04, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TMO EPS forecast?
          TMO EPS forecast for the fiscal quarter 2025 (Q4) is 6.45.

            Thermo Fisher (TMO) Earnings News

            Thermo Fisher (NYSE:TMO) Drops despite Exceeding Q4 Estimates
            Premium
            Market News
            Thermo Fisher (NYSE:TMO) Drops despite Exceeding Q4 Estimates
            2y ago
            Thermo Fisher (NYSE:TMO) Tanks on Lowered Outlook
            Premium
            Market News
            Thermo Fisher (NYSE:TMO) Tanks on Lowered Outlook
            2y ago
            Thermo Fisher (NYSE:TMO) Cools Down on Big Q2 Miss
            Premium
            Market News
            Thermo Fisher (NYSE:TMO) Cools Down on Big Q2 Miss
            2y ago
            Thermo Fisher Slides on Weak Q1
            Premium
            Market News
            Thermo Fisher Slides on Weak Q1
            3y ago
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis